Cargando…

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

BACKGROUND: The objective of this study was to estimate the prevalence of possible oral corticosteroid (OCS)-related side effects and health care resource use and costs in patients with asthma. METHODS: This was a cross-sectional, matched-cohort, retrospective study using a commercial claims databas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luskin, Allan T, Antonova, Evgeniya N, Broder, Michael S, Chang, Eunice Y, Omachi, Theodore A, Ledford, Dennis K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087584/ https://www.ncbi.nlm.nih.gov/pubmed/27822075 http://dx.doi.org/10.2147/CEOR.S115025

Ejemplares similares

Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria
por: Broder, Michael S., et al.
Publicado: (2015)

Administrative Claims Analysis of Asthma-Related Health Care Utilization for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol as Combination Therapy
por: Allen-Ramey, Felicia C., et al.
Publicado: (2006)

Health Care Utilization Determined From Administrative Claims Analysis for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol
por: Markson, Leona E., et al.
Publicado: (2006)

Asthma diagnosis and treatment – 1018. Effect of inhaled corticosteroids with long-acting beta2 agonists vs. inhaled corticosteroids alone on asthma control in children: results from national ashtma survey
por: Lockey, Richard F, et al.
Publicado: (2013)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma
por: Bodum, Karoline S., et al.
Publicado: (2022)

S107. HEALTHCARE UTILIZATION AND COST IN SCHIZOPHRENIA AND BIPOLAR DISORDER: REAL-WORLD EVIDENCE FROM US CLAIMS DATABASES
por: Greene, Mallik, et al.
Publicado: (2018)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims
por: Sacks, Naomi C, et al.
Publicado: (2021)

A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use
por: Appukkuttan, Sreevalsa, et al.
Publicado: (2019)

Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden
por: Mooney, Joshua J., et al.
Publicado: (2017)

The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents
por: Navaratnam, P, et al.
Publicado: (2010)

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis
por: Flórez-Tanus, Álvaro, et al.
Publicado: (2018)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Dynamics of inhaled corticosteroid use are associated with asthma attacks
por: Lee, Joy, et al.
Publicado: (2021)

Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
por: Accortt, Neil A., et al.
Publicado: (2017)

Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses
por: Almonacid, Carlos, et al.
Publicado: (2023)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2020)

Benign fasciculations and corticosteroid use: possible association? An update
por: Orsini, Marco, et al.
Publicado: (2011)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis
por: Benson III, Al B, et al.
Publicado: (2017)

Stepping down inhaled corticosteroid use in asthma - who is responsible?
por: Chaudhary, Ashbal, et al.
Publicado: (2015)

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management
por: Bleecker, Eugene R., et al.
Publicado: (2020)

Prevalence of oral corticosteroid use in the German severe asthma population
por: Taube, Christian, et al.
Publicado: (2019)

Use of corticosteroids in asthma and COPD patients with or without COVID-19
por: Hasan, Syed Shahzad, et al.
Publicado: (2020)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
por: Jones, Thomas L.
Publicado: (2021)

The use of systemic corticosteroids in asthma management in Latin American countries()
por: Maspero, Jorge F., et al.
Publicado: (2023)

Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
por: Yan, Tingjian, et al.
Publicado: (2018)

Systemic Side-Effects of Topical Corticosteroids
por: Dhar, Sandipan, et al.
Publicado: (2014)

Corticosteroids in the treatment of acute asthma
por: Alangari, Abdullah A.
Publicado: (2014)

Asthma: beyond corticosteroid treatment
por: Marandi, Yasser, et al.
Publicado: (2013)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history
por: Tabatabaian, Farnaz, et al.
Publicado: (2018)

Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma
por: Sullivan, Patrick W., et al.
Publicado: (2020)

Association of low-dosage systemic corticosteroid use with disease burden in asthma
por: Matsunaga, Kazuto, et al.
Publicado: (2020)

How can we minimise the use of regular oral corticosteroids in asthma?
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

Verifying a questionnaire diagnosis of asthma in children using health claims data
por: Yang, Connie L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0d51poqrebpmgmpsuo0kls56b4